Perlmutter-led Eikon ‍Therapeutics targets $908 million valuation in US IPO - Reuters

Reuters | Jan. 28, 2026, 6:38 a.m. | Original
Perlmutter-led Eikon ‍Therapeutics targets $908 million valuation in US IPO Reuters
Walmart boosts pharmacy pay, elevates 3,000 roles in healthcare push - Reuters Morning Bid: Making a weak dollar "great" again - Reuters